U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07340476) titled 'A Study to Evaluate the PK Similarity of AK112 in Healthy Chinese Male Subjects' on Jan. 06.
Brief Summary: The purpose of this study is to evaluate the pharmacokinetic (PK) similarity of AK112 (an anti-PD-1/VEGF bispecific antibody) from the proposed new manufacturing site and the approved original site in healthy male subjects.
Secondary objectives are to assess the safety, tolerability, and immunogenicity of AK112 from the proposed new manufacturing site and the approved original site.
Study Start Date: Dec. 11, 2025
Study Type: INTERVENTIONAL
Condition:
Healthy Male Subjects
Intervention:
DRUG: AK112 (New Site)
AK112 (Ne...